focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 114.50
Ask: 119.50
Change: 0.00 (0.00%)
Spread: 5.00 (4.367%)
Open: 119.00
High: 0.00
Low: 0.00
Prev. Close: 119.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

23 Feb 2024 10:30

RNS Number : 1814E
Xaar PLC
23 February 2024
 

23 February 2024

Xaar plc

Board Change

Xaar plc, ("the Company" or "Xaar"), a leading inkjet printing technology group, announces today the appointment of Stuart Widdowson to the Board as a Non-Executive Director effective from 27 February 2024.

Mr Widdowson is appointed as a representative of Odyssean Capital LLP ("Odyssean"), pursuant to a relationship agreement between the Company and Odyssean. The key terms are summarised in the notes below.

Mr Widdowson is the Managing Partner of Odyssean Capital, which he founded in 2017. From 2009 until 2017, he was lead fund manager of Strategic Equity Capital plc, which experienced a turnaround in its performance and rating during his tenure. He began his career as a strategy consultant undertaking commercial due diligence and strategy projects for private equity and corporate clients, before working for HgCapital, a leading private equity investor.

As at the last practicable date the total shareholding of funds managed by Odyssean Capital was 13,175,000 ordinary shares in the Company ("Ordinary Shares") representing approximately 16.6 per cent. of the Company's share capital. Additionally, Mr Widdowson beneficially owns 25,000 Ordinary Shares and the joint venture partner of Odyssean Capital, Harwood Capital, owns 1,050,000 Ordinary Shares.

Notes:

A summary of the key terms of the Relationship Agreement is as follows:

· Xaar has granted Odyssean the right to appoint Mr Widdowson to be a Director of the Company for appointment to the Board (the "Nominated Director") for so long as Odyssean has the right to exercise at least 10% or more of the Company's ordinary shares or voting rights attaching to the ordinary shares;

· Odyssean undertakes to, inter alia: (1) conduct all transactions and relationships with any member of Xaar's group on an arm's length basis; (2) not take any action which would have the effect of preventing Xaar or any member of Xaar's group from carrying on business independently of Odyssean or its associates; (3) not influence the day-to-day running of the Company (save through Mr Widdowson's role as the Nominated Director) and (4) not vote to prevent Xaar being managed in accordance with the principles of good governance set out in the UK Corporate Governance Code; and

· the Relationship Agreement will terminate (1) on the date upon which Odyssean ceases to hold at least 10% of the ordinary shares of the Company or the voting rights attaching to the ordinary shares of the Company; (2) on six months' notice written notice by either party at any time or immediately upon written notice in the event of a material breach of the Relationship Agreement; or (3) in the event that the Company's ordinary shares cease to be listed on the Official List or another recognised UK stock exchange.

Pursuant to Listing Rule 9.6.13, it is confirmed that Mr Widdowson was a director and shareholder of Durendal Limited, a fund management business, which was wound up in 2015. His shareholding was acquired by the majority shareholder and the cash was distributed to all shareholders before the company was voluntarily liquidated.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Stuart Widdowson to the Board.

Enquiries:

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATTMPTMTTTBFI
Date   Source Headline
4th Sep 20188:30 amRNSTotal Voting Rights
4th Sep 20188:05 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSTrading Update
1st Aug 20182:40 pmRNSTotal Voting Rights
12th Jul 20187:00 amRNSAnnouncement of 3D Printing Joint Investment
2nd Jul 20185:39 pmRNSBlock listing Interim Review
2nd Jul 20185:37 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 20182:25 pmRNSTotal Voting Rights
30th May 20187:00 amRNSBoard Change
22nd May 201812:12 pmRNSResult of AGM
1st May 20185:02 pmRNSTotal Voting Rights
11th Apr 201812:02 pmRNSPrice Monitoring Extension
5th Apr 20189:38 amRNSGrant of Options
3rd Apr 201812:26 pmRNSTotal Voting Rights
3rd Apr 201810:54 amRNSBoard Change
23rd Mar 20182:10 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSXaar plc 2017 Full Year Results
20th Mar 20181:25 pmRNSHolding(s) in Company
12th Mar 201810:58 amRNSHolding(s) in Company
1st Mar 20183:57 pmRNSTotal Voting Rights
2nd Feb 20188:00 amRNSNotice of Scheduled Results
1st Feb 201811:11 amRNSTotal Voting Rights
5th Jan 20187:00 amRNSBlock listing Interim Review
5th Jan 20187:00 amRNSIssue of Equity - Share Scheme and Block Listing
2nd Jan 20182:52 pmRNSTotal Voting Rights
14th Dec 201711:11 amRNSAgreement
1st Dec 20171:55 pmRNSTotal Voting Rights
21st Nov 20178:56 amRNSNOTIFICATION OF MAJOR HOLDINGS
20th Nov 20177:00 amRNSTrading Statement
15th Nov 20179:20 amRNSXaar strengthens 2020 vision with two developments
1st Nov 201710:04 amRNSTotal Voting Rights
2nd Oct 20172:37 pmRNSTotal Voting Rights
8th Sep 201711:34 amRNSDirector/PDMR Shareholding
6th Sep 20172:43 pmRNS2017 Interim Results
6th Sep 20177:00 amRNS2017 Interim Results
1st Sep 201712:21 pmRNSTotal Voting Rights
17th Aug 201711:55 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Aug 20177:00 amRNSDirector change
1st Aug 20172:26 pmRNSTotal Voting Rights
12th Jul 20177:00 amRNSTrading Statement
4th Jul 20177:00 amRNSNotice of Scheduled Trading Statement
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20179:36 amRNSBlock listing Interim Review
1st Jun 201711:33 amRNSTotal Voting Rights
18th May 201711:10 amRNSREPLACEMENT: Grant of Options
18th May 20178:56 amRNSGrant of Options
16th May 20171:24 pmRNSResult of AGM
2nd May 20171:13 pmRNSTotal Voting Rights
2nd May 20177:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.